STAT+: Illumina will launch Grail’s cancer detection test in Africa and Asia — but doesn’t know when
Sequencing company Illumina is planning to launch Galleri — the much-hyped cancer detection test from…
Author: STAT
STAT+: Could wearable tech — and AI — change how we diagnose infants with conditions like cerebral palsy?
An unlikely team of engineers and mobility researchers has developed an experimental set of small,…
STAT+: The four senators who could make or break Democrats’ drug pricing ambitions
WASHINGTON — The fate of the Democratic party’s ambitious goal of allowing Medicare to negotiate…
CDC advisory panel backs mix-and-match approach to Covid-19 vaccine boosters
An expert panel that advises the Centers for Disease Control and Prevention on vaccine policy…
Athira chief executive resigns as company confirms she altered research
The chief executive of biotech Athira Pharma has permanently left the company after papers she…
STAT+: FDA warns a hospital and two physicians for putting patients at ‘significantly increased’ risk in trials
In harsh tones, U.S. regulators warned a Minnesota hospital and two of its physicians for…
.jpg)
Listen: Inside the vaccine race, how a Covid pill failed, & Biogen’s troubled launch
Is Moderna misunderstood? Can Biogen turn a profit in Alzheimer’s disease? And what went wrong…
STAT+: Most women had no issues obtaining abortion pill from mail-order pharmacies
Amid national furor over abortion access, a new survey found most women were satisfied with…
WHO estimate: 115,000 health workers have died from Covid-19, as calls for vaccine access grow
Some 115,000 health care workers died from Covid-19 from January 2020 to May of this…
STAT+: Pharmalittle: Power for Medicare to negotiate drug prices grows less likely; FDA OKs mix-and-match Covid booster shots
Top of the morning to you. And a fine one it is. Crystal clear blue…
STAT+: MIT professor sues after he was forced to resign from institute following sexual harassment allegations
A prominent Massachusetts Institute of Technology biology professor who was forced two months ago to resign from…
STAT+: Amid a health tech consolidation wave, Everly Health acquires fertility startup Natalist
Riding a wave of consolidation in virtual care, home diagnostics brand Everly Health on Thursday…
Opinion: Making clinicians worthy of medical AI: Lessons from Tesla and self-driving cars
Tesla is in the midst of conducting an unprecedented social experiment: testing drivers of its…
.jpg)
Opinion: What the death rattle and capital punishment have in common
Death rattle. That’s the sound some dying people make, caused by a buildup of mucus…
STAT+: A disrupting force, or ‘just another mail order pharmacy’? How Amazon Pharmacy stacks up a year after launching
It was the launch that sent pharmacy stocks into a tailspin. Within hours of Amazon…
Half doses, third doses, kids’ doses: Covid vaccine delivery goes next-level difficult
The U.S. Covid-19 vaccine rollout is about to get a lot more complicated. When the…
STAT+: Senate Democrats push back on the notion that adding dental, vision to Medicare would bankrupt it
Key Senate Democrats used a hearing Wednesday to push back on the argument that expanding…
FDA authorizes booster shots of Moderna, Johnson & Johnson Covid-19 vaccines
Many Americans who have been vaccinated against Covid-19 will soon be able to choose which…
STAT+: Pulling back the curtain: U.K. to launch new system for registering clinical trials automatically
In its latest bid to boost clinical trial transparency, the U.K. government will automatically register…
STAT+: Pharmalittle: Gates commits $120 million to speed generic versions of Merck Covid-19 pill; sales of Biogen Alzheimer’s drug bomb
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Takeda strikes a rebate deal for lung cancer drug as health plans look to value-based agreements
In another bid to address the cost of prescription medicines, Takeda Pharmaceuticals (TAK) and 32PointHealth…
STAT+: Biogen’s Aduhelm sales fall dramatically below Wall Street’s expectations
Biogen made just $300,000 from the Alzheimer’s disease treatment Aduhelm in the first full quarter…
Opinion: Listen: A Filipinx physician on health disparities disguised by data
When data shows that Asian Americans are faring better during the pandemic than other racial…
Opinion: Telehealth skeptics miss the forest for the trees
The role of telehealth and its staying power in our health care system is up…
Philanthropist-funded study at a prestigious hospital raises thorny questions about clinical research
The opportunity seemed too good to pass up. It was 2020, and the CEO of…
STAT+: In a sea of skeptics, this physician was one of fibromyalgia patients’ few true allies. Or was he?
Cindy Bradley-Graziadei almost didn’t take the test. By the time she saw it advertised, in…
Gates Foundation will provide $120 million to ensure generic production of Merck’s Covid-19 pill
As concern mounts over access to Covid-19 remedies, the Bill & Melinda Gates Foundation is…
Sex of the fetus influences the mother’s response to Covid-19 infection, new research shows
In April 2020, as SARS-CoV-2 was first beginning to spread through New England, researchers at…
Elizabeth Warren on over-the-counter hearing aids, health lobbying, and the FDA’s independence
WASHINGTON — On Tuesday the Food and Drug Administration took a major step toward allowing…
Hacking third-party apps, Amazon’s lobbying strategy, & FDA’s next steps on AI
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
Opinion: Insurers should cover energy costs for prescribed medical equipment
Some Americans working from home during the pandemic noticed sizable increases in their monthly electric…
STAT+: STAT+ Conversation: Delving into digital biomarkers
Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: WHO hopes to buy Covid treatments for $10 a course; Sinema is a big obstacle to drug pricing reform
Rise and shine, another busy day is on the way. However, this is also shaping…
Atea’s antiviral pill fails to clear Covid-19, forcing a re-think
Atea Pharmaceuticals said Tuesday that its antiviral pill for Covid-19 failed to combat the virus…
Opinion: Investing in caregiving: a social, public health, and economic issue
As a working daughter, I recently embarked on a new and uncertain phase of my…
STAT+: Underpinning Sinema’s outspoken opposition to major drug pricing reforms: her close ties to Arizona biotechs
Phoenix, Ariz. is no Kendall Square. Its biotech companies, ventures like OncoMyx Therapeutics and VisionGate,…
STAT+: Amazon is beefing up its health care lobbying operation
WASHINGTON — Amazon is bulking up its efforts to influence health care policy at the…
Politics is derailing a crucial debate over the immunity you get from recovering from Covid-19
WASHINGTON — Among scientists, there’s little debate: People who get sick with Covid-19 develop at…
STAT+: UnitedHealthcare launches a virtual-first health insurance plan as hybrid care gains steam
The pandemic prompted a mad dash to figure out how to deliver health care virtually….
Black women die earlier and more often of breast cancer. Should they be screened sooner?
For years, health experts have recommended that, starting at the age of 50, every woman…
‘Make a gesture of humanity’: Pope Francis urges drug makers to release Covid-19 vaccine patents
Amid controversy over global access to Covid-19 vaccines, Pope Francis lent his moral authority to…
STAT+: FDA approves an interchangeable biosimilar version of Humira, but health care savings are dubious
For the first time, U.S. regulators have approved an interchangeable, biosimilar version of Humira, a…
STAT+: An FDA rejection derails Omeros, exposing the empty promises of its CEO
It’s remarkable to watch Omeros CEO Greg Demopulos and his executive team dissolve into a…
STAT+: ‘I don’t know anybody who wants their health disrupted’: Ken Frazier steps out in new venture capital role
Former Merck CEO Ken Frazier, famous for building the drugmaker into one of the world’s…
Opinion: On Covid-19 booster shots, the FDA has overstepped its role
Booster shots for all adults six months after being vaccinated against Covid-19 are safe, effective,…
STAT+: Pharmalittle: Biogen drug for rare form of ALS fails pivotal study; EU criticized over IP stance at WTO
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: The new vision for the now-merged Doctor on Demand and Grand Rounds begins to take shape
In May, two privately held health tech startups — Doctor on Demand and Grand Rounds…
Opinion: Rebuilding the nation’s health care workforce during and after Covid-19: Lessons from disaster management
As an emergency medicine physician and director of emergency management, I have taken part in…
STAT+: ‘My jaw dropped’: Basic security flaws in third-party apps leave millions of patient records at risk
In the last year, cyberattacks on hospitals have surged, putting a spotlight on the need…
Watch: What’s up with tranched deals in biotech?
Tranche is a French word meaning slice, and that’s pretty much what it means in…